Panacea Index Logo

Command Palette

Search for a command to run...

Impact of low iodine diets on ablation success in differentiated thyroid cancer: A mixed-methods systematic review and meta-analysis.

Clinical endocrinology
December 1, 2022
Georgia Herbert et al. (10 authors)
Meta-AnalysisSystematic ReviewJournal ArticleReviewResearch Support, Non-U.S. Gov'tHuman Study
Study Details

Study Goal

The researchers aimed to determine if iodine status affects radioactive-iodine treatment success, the effectiveness of low iodine diets (LID) in reducing iodine status, and the impact of LID on patient wellbeing.

Results Summary

The study found that lower iodine status (<50 mcg/L) was associated with greater ablation success compared to higher levels, though evidence certainty was very low. Stricter LIDs reduced iodine status more effectively but did not significantly improve treatment success. LIDs negatively impacted psychological health and were challenging for patients.

Population

Patients undergoing radioactive-iodine treatment (specific condition not detailed).

Effective Dosage

Not specified (focus on iodine status thresholds: <50 mcg/L vs. ≥250 mcg/L).

Duration

1-2 weeks for LID.

Interactions

None mentioned.

Extracted Claims (7)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low iodine diet (LID)
decrease
iodine status
-
-
reduces
#1
low iodine diet (LID)
increase
ablation success
those with an iodine status of <50 mcg/L (or mcg/gCr)
odds ratio [OR] = 2.63, 95% confidence interval [CI], 1.18-5.86, n = 283
had greater ablation success
#2
low iodine diet (LID)
no change
ablation success
those with an iodine status of <50 mcg/L (or mcg/gCr) compared to 100-199
OR = 1.59, 95% CI, 0.48-6.15, n = 113
showed similar rates of ablation success
#3
stricter low iodine diet (LID)
no change
ablation success
-
OR = 0.67, 95% CI, 0.26-1.73, n = 256
had similar rates of success
#4
stricter low iodine diet (LID)
decrease
iodine status
-
SMD = -0.40, 95% CI, -0.56 to -0.24, n = 816
reduced iodine status more
#5
low iodine diet (LID)
decrease
iodine status
-
after 1 and 2 weeks
reduction was seen
#6
low iodine diet (LID)
decrease
psychological health
patients
-
negative impact
#7
Abstract

BACKGROUND: Debate remains regarding whether to recommend a low iodine diet (LID) before radioactive-iodine treatment and its duration and stringency. This mixed-methods review aimed to determine if iodine status affects treatment success, the most effective diet to reduce iodine status, and how LID impacts wellbeing. METHODS: Five electronic databases were searched until February 2021. An effectiveness synthesis (quantitative studies) and views synthesis (qualitative, survey, and experience-based evidence) were conducted individually and then integrated. Quality assessment was undertaken. RESULTS: Fifty-six quantitative and three qualitative studies were identified. There was greater ablation success for those with an iodine status of &lt;50 mcg/L (or mcg/gCr) compared with ≥250 (odds ratio [OR] = 2.63, 95% confidence interval [CI], 1.18-5.86, n = 283, GRADE certainty of evidence very low). One study compared &lt;50 mcg/L (or mcg/gCr) to 100-199 and showed similar rates of ablation success (OR = 1.59, 95% CI, 0.48-6.15, n = 113; moderate risk of bias). People following a stricter LID before ablation had similar rates of success to a less-strict diet (OR = 0.67, 95% CI, 0.26-1.73, n = 256, GRADE certainty of evidence very low). A stricter LID reduced iodine status more than a less strict (SMD = -0.40, 95% CI, -0.56 to -0.24, n = 816), and reduction was seen after 1 and 2 weeks. The main challenges were a negative impact on psychological health, over restriction, confusion, and difficulty for sub-groups. CONCLUSIONS: Although a LID of 1-2 weeks reduces iodine status, it remains unclear whether iodine status affects treatment success as only a few low-quality studies have examined this. LIDs are challenging for patients. Higher-quality studies are needed to confirm whether a LID is necessary.

Medical Subject Headings (MeSH)
HumansIodineIodine RadioisotopesThyroid NeoplasmsDietTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality70/10
Citation Metrics
Total Citations4
Citations/Year1.3
Relative Citation Ratio0.63
NIH Percentile34%
Research Impact Scores
APT Score0.75
Weight Score2.28
Normalized Score0.60
Related Supplements